Live attenuated SA 14-14-2 vaccine
JEV02
Phase 3 mab completed
Quick answer
Live attenuated SA 14-14-2 vaccine for Encephalitis, Japanese B is a Phase 3 program (mab) at Repatha with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Repatha
- Indication
- Encephalitis, Japanese B
- Phase
- Phase 3
- Modality
- mab
- Status
- completed